Vifor Pharma, Inc.
Vifor Pharma, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels | Hyperkalemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, metabolic disease | Recruiting | Phase 2 | 2026-09-25 | NCT05766839 | |
| Potassium Correction for RAAS Optimization in Chronic Kidney Disease | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperkalemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, cardiovascular disorder, chronic renal failure syndrome, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, urinary system disorder, vascular disorder | Recruiting | Phase 4 | 2025-12-19 | NCT06256991 |